IRCT20200825048515N22 IRCT 2021-01-20 Esfahan University of Medical Sciences The effect of propofol and ketofol on restlessness after anesthesia in children Comparative study of the effect of propofol and ketofol on restlessness after anesthesia in children aged 18-6 months under cleft palate surgery 2021-01-04 anticipated 86 Complete https://irct.ir/trial/53182 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, 86 eligible patients will be randomly selected. Then, these patients will be randomly encoded using computer software called "Random Allocation" and automatically divided into two groups. The relevant codes will be entered in the raw checklists and each of these checklists will be randomly assigned to one patient and that patient will be randomly assigned to one of the two study groups, Blinding description: In this study, propofol and ketofol, are prepared by the pharmacist and placed in coded packages, and delivered daily to an anesthesiologist, who prescribes them without knowing the type of each drug. Also, the person recording the patient's clinical information and the statistical analyst will not be aware of the type of intervention. 2-3 Cleft palate. Intervention 1: First intervention group: Anesthesia induction is performed for patients by injecting 2 mg/kg propofol(Caspian Tamin Pharmaceutical), 2 μg/kg fentanyl(Caspian Tamin Pharmaceutical), and 0.5 mg/kg atracurium(Caspian Tamin Pharmaceutical). The propofol (Caspian Tamin Pharmaceutical) maintenance anesthesia is administered to the patient at 100 μg/kg/min with 50% oxygen. Intervention 2: Second intervention group: Anesthesia induction is performed for patients by injecting 2 mg/kg propofol(Caspian tamin Pharmaceutical), 2 μg/kg fentanyl(Caspian Tamin Pharmaceutical), and 0.5 mg/kg atracurium(Caspian Tamin Pharmaceutical). The maintenance anesthesia including a combination of propofol (Caspian Tamin Pharmaceutical) at a dose of 75 μg/kg/min and ketamine (Rotex Medica Pharmaceutical) at a dose of 25 μg/kg/min with 50% oxygen, is administered to the patient. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information